Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BASi Appoints Preclinical VP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

BASi Appoints Preclinical VP

Downing to lead drug discovery and early-stage development efforts

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Philip A. Downing has been promoted to vice president of Preclinical Services at BASi.
 
Mr. Philip has worked at BASi for 18 years, starting as an analytical chemist and gaining responsibilities in more progressive leadership roles throughout his tenure. Mr. Downing worked for a clinical research laboratory, GFi Pharmaceuticals (now Covance Labs) as an analytical scientist designing and validating radiolabeled and non-radiolabeled assays used to support clinical ADME studies.  
 
“Since joining BASi in 1997, Philip has always maintained a high level of focus on our clients’ needs throughout the full range of both GLP and non-GLP Preclinical and Nonclinical services including Discovery, PKPD, acute & chronic toxicology, DART, juvenile toxicology, and carcinogenicity studies supporting IND and NDA enabling programs offered at the BASi facility located near Evansville, IN. Under Philip’s leadership, we will broaden our collaborative outreach and build on an already outstanding track record of supporting our clients’ drug discovery and early-stage development efforts,” said Jacqueline Lemke, president and chief executive officer of BASi.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics